About the Company/Team

Vaxess Technologies is revolutionizing the delivery of vaccines and therapeutics through its proprietary MIMIX™ transdermal patch technology. This innovative solution allows for needle-free and refrigeration-free administration, making it suitable for self-administration in home and low-resource settings. The MIMIX™ patch utilizes advanced biomaterials to ensure precise dose delivery and is designed to enhance the effectiveness of next-generation vaccines and therapies, including mRNA and GLP-1. With a strong team of life scientists and engineers, Vaxess is positioned to transform healthcare accessibility and improve patient experiences globally.